The Challenger Ltd (ASX:CGF) share price has gone up 24% in a month

Challenger Ltd's (ASX:CGF) share price is going places.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Challenger Ltd (ASX: CGF) share price has risen an exciting 24% since 26 April 2018.

Challenger is Australia's market-leading annuity provider. The main purpose of its products is to provide retirees with a guaranteed source of income for their capital.

The main driver of this increase has been a regulatory change in the Federal Budget.

The Government will introduce a change to the superannuation system, requiring trustees to offer Comprehensive Income Products for Retirement (CIPRs) that provide individuals with income for life, no matter how long they live. There will also be new means test rules for lifetime retirement income stream products.

The new means test rules will allow for new products, such as a deferred lifetime annuity. These new rules will come into effect on 1 July 2019, which is the start of FY20.

According to Challenger, once the new rules come into effect, the total outcome for the retiree of the new retirement income stream and an account based pension will often be enhanced.

These new rules, combined with the ageing tailwind and superannuation growth, could be a big deal for Challenger in FY20 and beyond. The number of people over 65 is expected to increase by 75% over the next 20 years, which means a lot of people entering retirement – this is the most common time to take out an annuity.

The tax effectiveness of super, as well as the mandatory 9.5% contribution, is seeing the total superannuation pool grow at an impressive rate.

To me, this is growth on growth. There are more people going to retire with (hopefully) bigger superannuation balances in the future.

Foolish takeaway

Challenger is currently trading at 18x FY19's estimated earnings, which seems quite reasonable. There are risks to Challenger in the medium-term and long-term. Rising interest rates could have a negative impact on its balance sheet and we won't know how effective the company has been at estimating life expectancy for many years.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited. The Motley Fool Australia owns shares of and has recommended Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »